Wine increases survival in Non Hodgkin’s lymphoma patients

Drinking wine may increase survival among non-Hodgkin’s lymphoma patients. – Pre-diagnostic wine consumption may reduce the risk of death and relapse among non-Hodgkin’s lymphoma patients, according to an epidemiology study presented at the American Association for Cancer Research 100th Annual Meeting 2009.

A tiny drop of blood helps to assess cancer details

New alternative to biopsy detects subtle changes in cancer cells, Stanford study shows. – A drop of blood or a chunk of tissue smaller than the period at the end of this sentence may one day be all that is necessary to diagnose cancers and assess their response to treatment, say researchers at the Stanford University School of Medicine.

Grape seed extract may cure leukemia

Grape seed extract kills laboratory leukemia cells, proving value of natural compounds. – An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract.

A universal mechanism of aging is identified

New evidence may explain why it is that we lose not only our youthful looks, but also our youthful pattern of gene activity with age. – Researchers have discovered that DNA damage decreases a cell’s ability to regulate which genes are turned on and off in particular settings. This mechanism, which applies both to fungus and to us, might represent a universal culprit for aging.

New genes identified linked to lung cancer

Scientists find new genes linked to lung cancer. Discovery opens door to individualized treatment strategies. – Working as part of a multi-institutional collaboration, scientists at Washington University School of Medicine in St. Louis have assembled the most complete catalog to date of the genetic changes underlying the most common form of lung cancer.

New MS drug rituximab shows promise for multiple sclerosis

Genentech Inc. and Biogen Idec Inc.’s cancer drug Rituxan (rituximab) reduced brain lesions in multiple sclerosis patients. – A drug therapy, using rituximab, dramatically reduced the number of inflammatory lesions that form along nerve fibers in brains of multiple sclerosis patients, revealed by researchers recently.

Occupational cancer risk in fruit and veg growers, hairdressers

New research by staff at the University’s Centre for Public Health Research show occupational cancer risk in fruit and veg growers, hairdressers and sewing machinists. – Increased risk of cancer for occupational groups including hairdressers, sewing machinists, field crop and fruit and vegetable growers, reported by New Zealand researchers. Occupational cancers account for 330 deaths in New Zealand each year, about five per cent.

Researchers discover a pathway to turn off immune system

The research could lead to development of new drugs that turn off the immune system in patients with autoimmune diseases ? such as rheumatoid arthritis and lupus. – University of Minnesota researchers have discovered a new way to turn genes off in human T cells, a type of white blood cell that helps the immune system fight infections. Turning off genes, through a process known as mRNA decay, is important for regulating the body’s immune response after fighting infection.